The SCN1B gene helps control the sodium channels that let brain and heart cells send electrical signals. This gene plays an important role in keeping those signals well timed. If it does not work properly, signaling can become unstable, which may lead to seizures, developmental and learning problems, or heart rhythm changes in some people. Pathogenic variants in the SCN1B gene are best known for causing or contributing to epilepsy, including febrile seizures and some severe early childhood seizure conditions.
What is a gene?
Genes are stretches of DNA that hold instructions cells use to make molecules or manage processes throughout the body. Some genes provide the directions for building proteins, which do much of the cell’s work. Others mainly regulate when specific processes happen, where they happen, and how active they are. As a group, genes affect how the body grows and works, and they can also influence your response to food, stress, and medications. For a closer look at this subject, visit the LearnHub.
Overview
SCN1BGene function
What if the gene works
The SCN1B gene helps control how sodium channels work in nerve, heart, and muscle cells. This supports steady electrical signaling, including brain activity, heartbeat, and muscle movement.
Risk
What if the gene does not work
Variants in the SCN1B gene can range from milder changes linked to febrile seizures to more severe variants causing developmental and epileptic encephalopathy, often with earlier onset and developmental impact. Some variants are also linked to heart rhythm conditions such as Brugada syndrome.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently tailored specifically to pathogenic variants in the SCN1B gene. The SCN1B gene is being studied in epilepsy and heart rhythm research as a possible biomarker, but this has not yet changed standard care.
Conditions associated with SCN1B
Gene function
What if the gene works
Tiny electrical signals help your brain, heart, and muscles work together every day. The SCN1B gene helps fine tune sodium channels, the tiny gates that let charged particles move in and out of cells. This SCN1B gene function supports smooth communication between cells.
The SCN1B gene helps sodium channels open and close in a controlled way. This shapes the timing and strength of electrical messages in nerve cells, heart cells, and muscle cells.
Its protein helps sodium channels reach the cell surface and work as part of a stable channel group. This keeps the cell prepared to send signals when needed.
The SCN1B gene also helps neighboring cells connect through proteins on their surface. In the nervous system, this supports organized communication between cells and normal network setup.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
SCN1B gene variants can affect sodium channel function by changing the shape or amount of the beta-1 helper protein, which may keep channels from reaching the cell membrane or interacting normally with nearby proteins. Some variants partly reduce this support, while more disruptive variants can greatly weaken it or stop it. That range can influence how early epilepsy or heart rhythm problems linked to the SCN1B gene appear and how marked they are.
How variants are linked to conditions
The clearest finding is that SCN1B gene variants are linked to epilepsy, especially developmental and epileptic encephalopathy and generalized epilepsy with febrile seizures plus. Some people have frequent seizures starting in infancy or early childhood, while others have a milder epilepsy pattern with fever triggered seizures. A few SCN1B gene variants have also been associated with inherited heart rhythm conditions, but epilepsy is the main well-established connection.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common throughout the general population. Most of these variants do not have a direct effect on health and instead reflect normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are also involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the SCN1B gene. In families with an SCN1B change, risk and symptoms can vary from person to person, so personal guidance from a doctor or genetic counselor can help put genetic results in context.
Inheritance of SCN1B variants
For SCN1B, how variants of the SCN1B gene are inherited depends on the specific condition and the variant involved. Some SCN1B-related seizure conditions and heart rhythm conditions follow an autosomal dominant pattern, which means a parent with the variant can pass it to each child with a 50% chance. A rarer, more severe epilepsy linked to the SCN1B gene follows an autosomal recessive pattern, so a child usually inherits one altered copy from each parent. This means SCN1B inheritance is not described by a single pattern for every SCN1B-related condition.
What does my SCN1B result mean for my family?
SCN1B results can have different family implications depending on the condition linked to the variant. Some SCN1B-related epilepsy and heart rhythm conditions can run in families in a dominant way, so close relatives may also carry the variant, while rarer SCN1B-related epilepsy can happen when both copies are changed, which means parents may be healthy carriers and brothers or sisters could also be carriers or affected.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the SCN1B gene, labs use SCN1B genetic testing on a blood or saliva sample. The test reads the gene’s DNA sequence to spot variants and may show whether a finding helps explain a person’s seizures or whether more interpretation is needed.
When should I consider getting a genetic test?
Consider genetic testing for the SCN1B gene if you or your child has unexplained seizures, especially seizures triggered by fever, early-onset epilepsy, or a strong family history of epilepsy. Testing may also be considered when these features occur along with developmental concerns or certain inherited heart rhythm problems.
A genetic result is only one part of your health story
A genetic finding can provide valuable insight, but how much it explains varies based on the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, how strongly a drug acts, or how sensitive someone is to side effects. This helps explain why the same medication works well for one person, works less well for another, or causes unwanted effects in someone else. These differences are common and are one part of why treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. By studying the relationship between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body processes it. This information can support more informed and more individualized treatment decisions. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the SCN1B gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in guiding medication choices, so questions about medicines, side effects, or new symptoms are best discussed with your doctor.
History
The SCN1B gene entered medical genetics through research on electrical signaling in the brain and heart in the 1990s, when scientists identified the beta 1 subunit of sodium channels. Building on this early work, researchers connected SCN1B variants to generalized epilepsy with febrile seizures plus in 2000, marking an important step in understanding inherited seizure conditions. That finding helped show that epilepsy could arise not only from the main channel-forming genes, but also from supporting channel genes. Over time, descriptions became more precise as SCN1B was linked to a broader range of epilepsy presentations and some heart rhythm conditions. This history placed the SCN1B gene among the earlier sodium channel genes to shape modern thinking about inherited excitability conditions.